Emily M. Leproust, Chief Executive Officer at Twist Bioscience Corp (TWST), sold 356,546 shares at $151.46 ($56.3M) on 2026-09-17, disclosed to the SEC on 2026-09-21.
Scheduled sale ($56.3M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.46 | 2,440 | $370K | 0.7% |
| 2 | $152.21 | 6,644 | $1.0M | 1.8% |
| 3 | $153.40 | 3,399 | $521K | 0.9% |
| 4 | $154.17 | 4,175 | $644K | 1.1% |
| 5 | $155.46 | 13,378 | $2.1M | 3.7% |
| 6 | $156.47 | 9,097 |
| $1.4M |
| 2.5% |
| 7 | $157.49 | 32,260 | $5.1M | 9.0% |
| 8 | $158.09 | 232,173 | $36.7M | 65.2% |
| 9 | $159.53 | 23,884 | $3.8M | 6.8% |
| 10 | $160.44 | 14,493 | $2.3M | 4.1% |
| 11 | $161.49 | 11,169 | $1.8M | 3.2% |
| 12 | $162.31 | 2,565 | $416K | 0.7% |
| 13 | $163.39 | 869 | $142K | 0.3% |
| Total | $157.99 avg | 356,546 | $56.3M | 100% |
| Filing → |
| TWST | SELL | 2026-09-25 | $923K | — | Filing → |
| TWST | SELL | 2026-09-23 | $279K | — | Filing → |
| TWST | SELL | 2026-09-10 | $282K | — | Filing → |